Phase 2 Study of Irinotecan Liposome Injection, Oxaliplatin, 5-fluorouracil/Levoleucovorin in Japanese Participants Not Previously Treated for Metastatic Adenocarcinoma of the Pancreas

NCT06225999 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

41

Enrollment

OTHER

Sponsor class

Conditions

Metastatic Adenocarcinoma of the Pancreas

Interventions

DRUG: Irinotecan liposome injection (S095013)
DRUG: Oxaliplatin
DRUG: LLV (levoisomer form of leucovorin)
DRUG: 5- FU (5-Fluorouracil)

Sponsor

Institut de Recherches Internationales Servier